Severe aggression in rats induced by mescaline but not other hallucinogens
- PMID: 119274
- DOI: 10.1007/BF00428319
Severe aggression in rats induced by mescaline but not other hallucinogens
Abstract
Pairs of male Sprague-Dawley rats were administered mescaline, lysergic acid diethylamide (LSD), psilocin, N,N-dimethyltryptamine (DMT), 3,4-dimethoxyphenylethylamine (DMPEA), or 5-hydroxydopamine (5-OHDA) IP prior to being placed in a shock-elicited aggression situation. When foot shock was delivered, controls struck each other with their forepaws, but never engaged in either biting or injurious fighting. Mescaline-treated rats (50 or 250 mg) rarely struck each other, but engaged in nearly lethal biting. While LSD (25--400 micrograms/kg), psilocin (2.0 mg/kg), and DMT (5 mg/kg) produced some biting, this did not significantly differ from controls and never resulted in injuries. At higher doses, psilocin, DMT, and DMPEA decreased the amount and intensity of fighting. Rats treated with 5-OHDA (8--200 mg/kg) or LSD (25--400 micrograms/kg) did not differ from controls. These results suggest that mescaline's ability to induce pathological aggression in rats exposed to foot shock is not shared by other hallucinogens or nonhallucinogenic mescaline analogues.
Similar articles
-
The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.J Pharmacol Exp Ther. 1978 Dec;207(3):837-47. J Pharmacol Exp Ther. 1978. PMID: 731434
-
Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.Pharmacol Biochem Behav. 1984 Aug;21(2):281-7. doi: 10.1016/0091-3057(84)90227-2. Pharmacol Biochem Behav. 1984. PMID: 6483939
-
Mescaline produces pathological aggression in rats regardless of age or strain.Pharmacol Biochem Behav. 1978 May;8(5):543-6. doi: 10.1016/0091-3057(78)90385-4. Pharmacol Biochem Behav. 1978. PMID: 566933
-
Effects of psychodysleptics on aggressive behavior of animals.Mod Probl Pharmacopsychiatry. 1978;13:103-13. doi: 10.1159/000401053. Mod Probl Pharmacopsychiatry. 1978. PMID: 415228 Review. No abstract available.
-
The Resurgence of Hallucinogen Drugs in Clinical Research.Rev Invest Clin. 2023;75(3):169-178. doi: 10.24875/RIC.23000108. Rev Invest Clin. 2023. PMID: 37441761 Review.
Cited by
-
Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):194-202. doi: 10.1016/j.pnpbp.2012.01.003. Epub 2012 Jan 9. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22251567 Free PMC article.
-
Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.Psychopharmacology (Berl). 2009 Jul;204(4):715-24. doi: 10.1007/s00213-009-1501-z. Epub 2009 Mar 14. Psychopharmacology (Berl). 2009. PMID: 19288085 Free PMC article.
-
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.ACS Chem Neurosci. 2019 Jul 17;10(7):3261-3270. doi: 10.1021/acschemneuro.8b00692. Epub 2019 Mar 4. ACS Chem Neurosci. 2019. PMID: 30829033 Free PMC article.
-
Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology (Berl). 2025 Jul;242(7):1607-1625. doi: 10.1007/s00213-024-06644-3. Epub 2024 Jul 4. Psychopharmacology (Berl). 2025. PMID: 38963553 Free PMC article.
-
Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose.Psychopharmacology (Berl). 2008 Jan;196(1):51-62. doi: 10.1007/s00213-007-0926-5. Epub 2007 Oct 7. Psychopharmacology (Berl). 2008. PMID: 17922234
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources